CLS Releases White Paper Regarding its imILT® Immuno-Stimulating Method for Treating Cancer Tumours at ECIO 2019 Conference

NEXT STORY
PCI Biotech: Final confirmation of successful safety read-out in the Phase I Extension study
PREV STORY
Genkyotex to Present Updated Interim Results From Phase 2 Trial of GKT831 in Primary Biliary Cholongitis at 2019 EASL International Liver Congress (ILC)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novartis delivers solid Q3 performance with 11% core operating income growth, net sales in line with prior year, strong pipeline progression. Upgrades full year core operating income guidance.

author_avatar
NASDAQ Market News

Global Hand Sanitizer Market Is Expected to Reach USD 2.14 Billion by 2027 : Fior Markets

author_avatar
NASDAQ Market News

RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81

author_avatar
NASDAQ Market News